Arkolith/Insider Trading/RAPP/Form 4

Paul Steven M

DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Sep 15, 2025
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2025Buy(P)28K$24.50$693K28K
Sep 12, 2025Buy(P)13K$24.97$334K42K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-203537) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML